Purpose: Atypical protein kinase Ciota (PKCiota) is an oncogene in non-small cell lung cancer (NSCLC). Here, we identify four functional gene targets of PKCiota in lung adenocarcinoma (LAC), the most prominent form of NSCLC.
Experimental Design: Three independent public domain gene expression data sets were interrogated to identify genes coordinately expressed with PKCiota in primary LAC tumors. Results were validated by QPCR in an independent set of primary LAC tumors. RNAi-mediated knockdown of PKCiota and the target genes was used to determine whether expression of the identified genes was regulated by PKCiota, and whether these target genes play a role in anchorage-independent growth and invasion of LAC cells.
Results: Meta-analysis identified seven genes whose expression correlated with PKCiota in primary LAC. Subsequent QPCR analysis confirmed coordinate overexpression of four genes (COPB2, ELF3, RFC4, and PLS1) in an independent set of LAC samples. RNAi-mediated knockdown showed that PKCiota regulates expression of all four genes in LAC cells, and that the four PKCiota target genes play an important role in the anchorage-independent growth and invasion of LAC cells. Meta-analysis of gene expression data sets from lung squamous cell, breast, colon, prostate, and pancreas carcinomas, as well as glioblastoma, revealed that a subset of PKCiota target genes, particularly COPB2 and RFC4, correlate with PKCiota expression in many tumor types.
Conclusion: Meta-analysis of public gene expression data are useful in identifying novel gene targets of oncogenic PKCiota signaling. Our data indicate that both common and cell type-specific signaling mechanisms contribute to PKCiota-dependent transformation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260476 | PMC |
| http://dx.doi.org/10.1158/1078-0432.CCR-08-2459 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cell polarity proteins promote macropinocytosis in response to metabolic stress.
Nat Commun
December 2024
Cancer Metabolism and Microenvironment Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Article Synopsis
- Macropinocytosis is a survival strategy used by cancer cells, especially in nutrient-poor environments, relying heavily on glutamine to sustain themselves, particularly in pancreatic ductal adenocarcinoma (PDAC) cells.
- The atypical protein kinase C (aPKC) enzymes, specifically PKCζ and PKCι, play a crucial role in regulating macropinocytosis by interacting with scaffold proteins that influence cell structure and function.
- The research shows that aPKCs enhance macropinocytosis through the relocation of Par3 to microtubules, and their depletion adversely affects cell viability, which can be reversed by restoring macropinocytosis, highlighting the significance of aPKCs in supporting
Article Synopsis
- Macropinocytosis is a survival mechanism for cancer cells, especially in nutrient-poor environments like tumors, allowing them to scavenge nutrients such as glutamine.
- In pancreatic ductal adenocarcinoma (PDAC), the atypical protein kinase C (aPKC) enzymes, specifically PKCζ and PKCι, play a crucial role in regulating this nutrient uptake process.
- The study reveals that these aPKCs interact with cell polarity proteins and are influenced by EGFR signaling and the CREM transcription factor to facilitate macropinocytosis, which is essential for the growth and survival of PDAC cells in vivo.
PKCiota Inhibits the Ferroptosis of Esophageal Cancer Cells via Suppressing USP14-Mediated Autophagic Degradation of GPX4.
Antioxidants (Basel)
January 2024
Medical School, Kunming University of Science and Technology, Kunming 650500, China.
Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignant tumors, and the mechanisms underlying the anti-ferroptosis of esophageal cancer cells are still largely unclear. This study aims to explore the roles of amplified protein kinase C iota (PKCiota) in the ferroptosis of ESCC cells. Cell viability, colony formation, MDA assay, Western blotting, co-IP, PLA, and RNA-seq technologies are used to reveal the roles and mechanisms underlying the PKCiota-induced resistance of ESCC cells to ferroptosis.
View Article and Find Full Text PDF14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression.
Front Oncol
January 2023
Department of Chemistry, University of South Florida, Tampa, FL, United States.
Neuroblastoma (NB) is a cancer that develops in the neuroblasts. It is the most common cancer in children under the age of 1 year, accounting for approximately 6% of all cancers. The prognosis of NB is linked to both age and degree of cell differentiation.
View Article and Find Full Text PDFIncreased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling.
Cancers (Basel)
December 2022
Cell and Experimental Pathology, Department of Translational Medicine, Lund University, Clinical Research Centre, Skåne University Hospital, SE 20213 Malmö, Sweden.
Treatment of melanoma with a BRAF inhibitor (BRAFi) frequently initiates development of BRAFi resistance, leading to increased tumor progression and metastasis. Previously, we showed that combined inhibition of elevated WNT5A and IL-6 signaling reduced the invasion and migration of BRAFi-resistant (BRAFi-R) melanoma cells. However, the use of a combined approach per se and the need for high inhibitor concentrations to achieve this effect indicate a need for an alternative and single target.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!